Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?
Chien‐Ning Hsu, You‐Lin Tain
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3954-3954
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Chronic kidney disease-induced muscle atrophy: Molecular mechanisms and promising therapies
Kexin Wang, Liu Qing-yuan, Mingyu Tang, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115407-115407
Open Access | Times Cited: 39
The Kidney–Gut Axis as a Novel Target for Nutritional Intervention to Counteract Chronic Kidney Disease Progression
Sandra Cabała, M. Ożgo, A. Herosimczyk
Metabolites (2024) Vol. 14, Iss. 1, pp. 78-78
Open Access | Times Cited: 8
Shenshuaikang enema restores the intestinal barrier and microbiota-gut-kidney axis balance to alleviate chronic kidney disease via NF-κB pathway
Ye Yan, Xiaopeng Huang, Xueying Li, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Exploring a Complex Interplay: Kidney–Gut Axis in Pediatric Chronic Kidney Disease
Adriana Mocanu, Roxana Alexandra Bogos, Tudor Ilie Lazaruc, et al.
Nutrients (2023) Vol. 15, Iss. 16, pp. 3609-3609
Open Access | Times Cited: 17
Role of the Gut Microbiota in Children with Kidney Disease
You‐Lin Tain, Chien‐Ning Hsu
Children (2023) Vol. 10, Iss. 2, pp. 269-269
Open Access | Times Cited: 14
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
Dan Linetzky Waitzberg, Francisco Guarner, Iva Hojsak, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 901-914
Open Access | Times Cited: 5
Dietary Resveratrol Butyrate Monoester Supplement Improves Hypertension and Kidney Dysfunction in a Young Rat Chronic Kidney Disease Model
You‐Lin Tain, Chi‐I Chang, Chih‐Yao Hou, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 635-635
Open Access | Times Cited: 13
Hesperidin alleviates zinc-induced nephrotoxicity via the gut-kidney axis in swine
Qingwen Yang, Qian Lv, Shanshan He, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 3
Sulfur-Containing Amino Acids, Hydrogen Sulfide, and Sulfur Compounds on Kidney Health and Disease
Chih‐Jen Chen, Ming‐Chou Cheng, Chien‐Ning Hsu, et al.
Metabolites (2023) Vol. 13, Iss. 6, pp. 688-688
Open Access | Times Cited: 10
An Overview of Chronic Kidney Disease Pathophysiology: The Impact of Gut Dysbiosis and Oral Disease
Serena Altamura, Davide Pietropaoli, Francesca Lombardi, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3033-3033
Open Access | Times Cited: 10
Perinatal Propionate Supplementation Protects Adult Male Offspring from Maternal Chronic Kidney Disease-Induced Hypertension
You‐Lin Tain, Chih‐Yao Hou, Guo‐Ping Chang‐Chien, et al.
Nutrients (2022) Vol. 14, Iss. 16, pp. 3435-3435
Open Access | Times Cited: 17
Bibliometric Analysis of the Relationship between Gut Microbiota and Chronic Kidney Disease from 2001–2022
Pengyu Tao, Jinlin Huo, Ling Chen
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 1
Closed Access | Times Cited: 2
Preventive effect of Lactobacillus johnsonii YH1136 against uric acid accumulation and renal damages
Xingting Zhang, Junliang Jiang, Jinge Xin, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Prediction and causal inference of hyperuricemia using gut microbiota
Yuna Miyajima, Shigehiro Karashima, Ren Mizoguchi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
A Network Pharmacology and Molecular-Docking-Based Approach to Identify the Probable Targets of Short-Chain Fatty-Acid-Producing Microbial Metabolites against Kidney Cancer and Inflammation
Md Rezaul Karim, Md. Niaj Morshed, Safia Iqbal, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1678-1678
Open Access | Times Cited: 7
Gutted: constipation in children with chronic kidney disease and on dialysis
Mandy Wan, Lillian King, Natasha Baugh, et al.
Pediatric Nephrology (2023) Vol. 38, Iss. 11, pp. 3581-3596
Open Access | Times Cited: 6
The NOS/NO System in Renal Programming and Reprogramming
You‐Lin Tain, Chien‐Ning Hsu
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1629-1629
Open Access | Times Cited: 6
Drugs with a negative impact on cognitive functions (Part 3): Antibacterial agents in patients with chronic kidney disease
Sophie Liabeuf, Gaye Hafez, Vesna Pešić, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 8
Open Access | Times Cited: 1
Natural polysaccharides as promising reno-protective agents for the treatment of various kidney injury
Yufei Ye, Maoting Li, Wei Chen, et al.
Pharmacological Research (2024) Vol. 207, pp. 107301-107301
Open Access | Times Cited: 1
Maternal Polyphenols and Offspring Cardiovascular–Kidney–Metabolic Health
You‐Lin Tain, Chien‐Ning Hsu
Nutrients (2024) Vol. 16, Iss. 18, pp. 3168-3168
Open Access | Times Cited: 1
Perinatal Oxidative Stress and Kidney Health: Bridging the Gap between Animal Models and Clinical Reality
You‐Lin Tain, Chien‐Ning Hsu
Antioxidants (2022) Vol. 12, Iss. 1, pp. 13-13
Open Access | Times Cited: 9
Hydrogen sulfide in health and diseases: cross talk with noncoding RNAs
Qing-Bo Lu, Yi Ding, Xiao Fu, et al.
AJP Cell Physiology (2023) Vol. 324, Iss. 4, pp. C856-C877
Closed Access | Times Cited: 4
The Impact of Nutrient Intake and Metabolic Wastes during Pregnancy on Offspring Hypertension: Challenges and Future Opportunities
You‐Lin Tain, Chien‐Ning Hsu
Metabolites (2023) Vol. 13, Iss. 3, pp. 418-418
Open Access | Times Cited: 4
Chronic Kidney Disease: Underlying Molecular Mechanisms—A Special Issue Overview
Luı́s Belo, Márcia Carvalho
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12363-12363
Open Access | Times Cited: 4
Probiotics mitigate kidney damage after exposure to Sri Lanka's local groundwater from chronic kidney disease with uncertain etiology (CKDu) prevalent area in zebrafish
Ling-Kang Bu, Pan‐Pan Jia, LI Wei-guo, et al.
Aquatic Toxicology (2023) Vol. 262, pp. 106671-106671
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top